Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Acta Medica Martiniana
Volume 17 (2017): Issue 3 (December 2017)
Open Access
Biosimilar medicines and patient registries – expectations, limitations, and opportunities
R Sutka
R Sutka
,
J Pec
J Pec
and
T Pecova
T Pecova
| Feb 20, 2018
Acta Medica Martiniana
Volume 17 (2017): Issue 3 (December 2017)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Feb 20, 2018
Page range:
39 - 51
Received:
Jan 01, 2018
Accepted:
Jan 26, 2018
DOI:
https://doi.org/10.1515/acm-2017-0016
Keywords
biology therapy registries
,
biosimilars
,
biologically similar drugs
,
HTA (health technology assessment)
© 2017 Sutka R et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
R Sutka
Dermatovenerology Clinic, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital
Martin, Slovakia
J Pec
Dermatovenerology Clinic, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital
Martin, Slovakia
T Pecova
Dermatovenerology Clinic, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital
Martin, Slovakia